Rajesh Exports Shares Extend 5-Day Rally to 28% From SEBI Order Low on 19 June 2026; Now Only 11% Below Pre-Order Level but Regulatory Risks Remain

Rajesh Exports Rs 97.51 (NSE BZ upper circuit; 5th consecutive session) on 19 Jun 2026. 5-day rally +28% from Rs 76.41. Down 11% from pre-SEBI order Rs 109.38. Under SEBI probe.

Rajesh Exports share price hit the 5% upper circuit at Rs 97.51 on the NSE BZ segment on 19 June 2026, extending its recovery to a fifth consecutive session of 5% upper circuits since the bounce began on 15 June 2026. From the post-SEBI order intraday low of approximately Rs 76.41 (June 12), the stock has now rallied approximately 28%, recouping a significant portion of the approximately 30% decline triggered by SEBI’s 109-page interim order of 3 June 2026, which alleged that Rajesh Exports misrepresented consolidated revenues of approximately Rs 15.15 lakh crore between FY2020-21 and FY2024-25. At Rs 97.51, Rajesh Exports is now only approximately 11% below the pre-SEBI order close of Rs 109.38, though the stock remains in the SEBI-mandated BZ (trade-for-trade) segment with significant ongoing regulatory risk.

Click Here – Get Free Investment Predictions

Rajesh Exports Key Data and SEBI Timeline

The 5-Day Rajesh Exports Recovery: What Is Driving It and What Remains at Risk

Rajesh Exports has rallied approximately 28% in five consecutive upper circuit sessions (June 15-19) from the post-SEBI order low of Rs 76.41. This recovery follows a 7-day lower circuit streak (June 4-12) that wiped out approximately 30% of the stock’s market value from the June 3 close of Rs 109.38. The rally appears to be driven by three factors: short covering by traders who had bet on continued declines, speculative interest from high-risk investors accumulating at extreme oversold technical levels, and the absence of immediate new negative catalysts after the initial SEBI order shock. Critically, none of the underlying regulatory concerns have been resolved.

Use the Univest Screener to track Rajesh Exports and monitor regulatory updates

The SEBI Order: What Was Alleged and What Has Happened Since

1. The Rs 15.15 Lakh Crore Revenue Allegation: Scale and Implications

The scale of the SEBI allegation against Rajesh Exports is extraordinary even by Indian regulatory standards. An alleged Rs 15.15 lakh crore in consolidated revenue misrepresentation over five years (FY21-FY25) would make this one of the largest alleged accounting fraud cases by revenue quantum in Indian corporate history. SEBI alleged that between 97-99% of all consolidated revenues were attributed to Valcambi SA, the Swiss gold refinery, and that these revenues could not be verified through documentation requests. Whether the allegation is ultimately upheld in a full adjudication process remains to be seen, but the interim order represents a severe regulatory action that investors cannot dismiss on the basis of the temporary stock price recovery.

2. T2T Settlement: The Trading Risk Investors Must Understand

The BZ designation means Rajesh Exports trades on a trade-for-trade basis. Unlike normal equity stocks where daily price discovery can involve intraday reversals and net settlement, every buy in Rajesh Exports must be paid fully and delivered; every sell must be backed by actual demat holdings. Speculative trading without delivery intent carries higher risk of auction settlement penalties. The 5% daily circuit limits (both upper and lower) mean the stock can move no more than 5% in either direction per session, creating a slow-burn pattern where the market absorbs or rejects news across multiple sessions.

3. The Remaining 11% Gap to Pre-SEBI Order Levels

At Rs 97.51, Rajesh Exports is approximately 11% below the pre-SEBI order close of Rs 109.38. Whether the stock recovers this gap depends entirely on the outcome of the SEBI investigation. If the forensic audit finds the revenue issues are limited to accounting classification rather than actual fraud, markets might price the stock closer to pre-order levels. If the audit confirms the alleged misrepresentations, the stock faces a significantly lower fundamental valuation given the Q4 FY26 net loss of Rs 53.50 crore and the complete loss of credibility in the consolidated revenue figure, which had been the primary valuation metric.

Download the Univest iOS App or Univest Android App to track Rajesh Exports share price live and monitor regulatory developments on Univest.

Conclusion

Rajesh Exports share price hit the 5% upper circuit at Rs 97.51 (NSE BZ) on 19 June 2026, marking its fifth consecutive upper circuit session since the bounce began on June 15. The 5-day rally of approximately 28% from the Rs 76.41 post-SEBI order low has recovered a significant portion of the SEBI-triggered decline, leaving the stock approximately 11% below the pre-SEBI order close of Rs 109.38. The recovery is technical and speculative in nature: the SEBI interim order alleging Rs 15.15 lakh crore in revenue misrepresentation remains active, the CMD is barred from markets, NFRA is probing the auditors, and MCA or SFIO investigation may follow. Investors should approach this stock with extreme caution. Consult a SEBI-registered financial advisor before investing.

Why is Rajesh Exports share price rising today in the upper circuit?

Ans. Rajesh Exports share price is hitting the 5% upper circuit for a fifth consecutive session on June 19, 2026, extending a technical recovery from deeply oversold levels. The 7-day lower circuit streak following the SEBI June 3 interim order drove the stock to an extreme oversold position near its 52-week low of Rs 77.05. The recovery appears to be driven by short covering and speculative buying at beaten-down levels. Importantly, the underlying SEBI investigation into alleged Rs 15.15 lakh crore revenue misrepresentation has not been resolved, and the stock remains in the high-risk BZ (trade-for-trade) segment.

What is the Rajesh Exports SEBI order about?

Ans. SEBI issued a 109-page interim ex-parte order on June 3, 2026, signed by Whole Time Member Kamlesh Chandra Varshney, alleging that Rajesh Exports misrepresented its consolidated revenues by approximately Rs 15.15 lakh crore between FY2020-21 and FY2024-25. SEBI alleged that between 97-99% (approximately 99.8%) of the company’s total consolidated revenues during this period were attributed to overseas subsidiaries, primarily Valcambi SA, the company’s Swiss gold refinery, and that these revenues could not be independently verified. SEBI also alleged non-genuine transactions, fund diversion through promoter-linked entities, and inadequate investor disclosures.

Has Rajesh Exports’ CMD Rajesh Mehta challenged the SEBI order?

Ans. No. Rajesh Exports’ Chairman and Managing Director Rajesh Mehta publicly stated that he will not challenge SEBI’s interim order. The company also stated it will fully cooperate with the fresh forensic audit ordered by SEBI. These statements, while signalling a non-confrontational approach, have had limited market impact on the regulatory overhang. SEBI has directed Rajesh Exports to submit requisite documents and explanations within 30 days of the June 3 order, cooperate with the investigating authority, and make true and fair disclosures in all financial filings going forward.

What are the additional regulatory risks facing Rajesh Exports?

Ans. Beyond the SEBI interim order, Rajesh Exports faces additional regulatory risks. Sources have indicated that the Ministry of Corporate Affairs (MCA) or Serious Fraud Investigation Office (SFIO) may initiate an independent investigation into the company. The National Financial Reporting Authority (NFRA) has also initiated an investigation into Rajesh Exports’ statutory auditors following a reference from SEBI. These potential multi-agency investigations significantly widen the regulatory risk exposure beyond the current SEBI probe and could lead to further restrictions on the company or its management.

What does BZ segment (trade-for-trade) mean for Rajesh Exports investors?

Ans. The BZ designation on NSE means Rajesh Exports is categorised under Trade for Trade (T2T) settlement, which requires that every trade must result in delivery. Unlike normal equities, there is no intraday buying and selling (squaring off without delivery is not allowed). All purchases must be paid for fully and delivered into the demat account; similarly, all sales must be backed by actual shares in the demat account. This category significantly reduces liquidity, increases settlement risk for investors, and is typically applied by exchanges to stocks under regulatory scrutiny or with high speculation risk. Investors should be aware of these trading restrictions.

What is Rajesh Exports’ 52-week range and how much has it corrected?

Ans. Rajesh Exports reached a 52-week high of approximately Rs 237.88-239 on December 22, 2025, and subsequently fell to a 52-week low of approximately Rs 77.05, touched on June 12, 2026, the day of the 7th consecutive lower circuit following the SEBI order. At the current upper circuit level of Rs 97.51 (NSE BZ), the stock is approximately 59% below the 52-week high and approximately 26% above the 52-week low. Before the SEBI order was issued, the stock had already corrected from its December 2025 high to approximately Rs 109 (Rs 110 range), a fall of approximately 54% from the 52-week high even before the regulatory action.

Who are Rajesh Exports and what business do they run?

Ans. Rajesh Exports Limited is a Bengaluru-based gold jewellery manufacturer and exporter. It claims to be the world’s largest gold manufacturing facility with the capacity to process 250 tonnes of jewellery and gold products annually at its Bengaluru plant. The company is also the parent of Valcambi SA, a Switzerland-based gold refinery that SEBI says accounted for the disputed overseas subsidiary revenues. Rajesh Exports exports gold jewellery primarily to Middle Eastern and Asian markets and also serves domestic retail markets. Face value of the equity share is Re 1. The company had a market cap of approximately Rs 3,068-3,090 crore at pre-SEBI order prices.

Should investors buy Rajesh Exports shares at the current recovery level?

Ans. Investors should exercise extreme caution regarding Rajesh Exports shares. The stock is in the BZ (trade-for-trade) segment, is under a SEBI interim order alleging Rs 15.15 lakh crore in revenue misrepresentation, may face additional SFIO and MCA investigations, and has its auditors under NFRA scrutiny. The 28% recovery from the recent lows appears to be driven by short covering and speculative momentum rather than fundamental improvement, as the SEBI investigation is ongoing and the company’s financial statements have been questioned. The Q4 FY26 net loss of Rs 53.50 crore vs a profit in the year-ago period adds to fundamental concerns. Consult a SEBI-registered financial advisor before making any investment decisions in this stock.